Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of Cellistic is 1.7% (average). The company has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
Based on State Gazette and CBE data.
Financials
No processed annual-account figures available.
To financials
People & board
3 mandates
1
active director
Jason ConnerDirector+2 in history
All directors & mandates Publicationslatest 07-05-2026
14
publications in the State Gazette2 directors appointed, 3 resigningAll publications & acts Network & structure
2
connected companiesSee network & structure
Connections
2 connected companiesTrust signals
3 signalsMore than 3 years active
Founded in 2020 — past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags
0 events
No administrative flags
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone1.7%
Average
0%0,5%1,5%4%10%≥25%
Young company
+Multiple establishment units
+Lower-risk legal form
−
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Company registry (CBE)
Crossroads BankActivities
Vervaardiging van geneesmiddelen21201Vervaardiging van geneesmiddelen21201Speur- en ontwikkelingswerk op biotechnologisch gebied72101Speur- en ontwikkelingswerk op biotechnologisch gebied72110Vervaardiging van farmaceutische grondstoffen21100Vervaardiging van farmaceutische grondstoffen21100
Primary activity highlighted.
Names & trade names
| Legal nameFR | Cellistic |
Registered office
Rue Edouard Belin 2
1435 Mont-Saint-Guibert, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.